Atlas Trials

Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine

Clinical trial NCT06412965 · COMPLETED

Trial details

NCT number
NCT06412965
Sponsor
Pfizer
Status
COMPLETED
Study type
OBSERVATIONAL
Migraine Disorders
Start date
2024-01-02
Primary completion
2024-01-03
Enrollment
528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.